BGCS uterine cancer guidelines: Recommendations for practice - ScienceDirect Skip to
main contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View …

The genetic, biologic, and clinical heterogeneity of sarcomas poses a challenge for the
identification of therapeutic targets, clinical research, and advancing patient care. Because …

Adenosarcomas are rare malignancies of the female genital tract, accounting for
approximately 5% of uterine sarcomas. Occasionally, adenosarcoma occurs in the ovaries …

The remit of this guideline is to collate and propose evidence-based guidelines for the
diagnosis and management of uterine cancer. This document covers all uterine cancers of …

Uterine adenosarcomas (UAs) are biphasic lesions composed of a malignant mesenchymal
(ie stromal) component and an epithelial component. UAs are generally low‐grade and …

Uterine sarcomas (US) are rare mesenchymal tumours accounting approximately for 3%–
7% of all uterine cancers. Histologically, US are classified into mesenchymal tumours or …

Background Uterine sarcomas are very rare tumours with different histotypes, molecular
features and clinical outcomes; therefore, it is difficult to carry out prospective clinical trials …

Soft tissue sarcomas (STS) are rare tumours arising in mesenchymal tissues and can occur
almost anywhere in the body. Their rarity, and the heterogeneity of subtype and location …

Uterine sarcomas (US) are rare mesenchymal tumours of the uterus and are divided mainly
into uterine leiomyosarcoma (uLMS), low grade endometrial stromal sarcoma (LG-ESS) …

Genitourinary tract soft-tissue sarcomas are rare neoplasms with varied pathologic and
clinical features. While some of these tumors may be aggressive high-grade malignancies …